SCHEMBL6403160

SCHEMBL6403160

Cc1ccc(N)c(Cl)c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 9/20 0.46
ALDH1A1 P00352 8/20 0.41
TSHR P16473 5/20 0.39
TDP1 Q9NUW8 7/20 0.39
POLB P06746 2/20 0.39
CASP1 P29466 2/20 0.39
CD44 P16070 1/20 0.39
MAPT P10636 2/20 0.38
THRB P10828 2/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
APEX1 P27695 1/20 0.38
RECQL P46063 1/20 0.38
RAB9A P51151 1/20 0.38
BLM P54132 1/20 0.38
KMT2A Q03164 1/20 0.38
MCL1 Q07820 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PIK3CA P42336 1/20 0.38
NOS3 P29474 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3884369 0.83 CYP3A4 (0.50) CYP3A4ALDH1A1TSHRTDP1POLB
SCHEMBL30785388 0.83 ALDH1A1 (0.50) CYP3A4ALDH1A1TSHRTDP1POLB
SCHEMBL8960736 0.83 ALDH1A1 (0.50) CYP3A4ALDH1A1TSHRTDP1POLB
SCHEMBL526351 0.80 ALDH1A1 (0.50) CYP3A4ALDH1A1TSHRTDP1POLB
SCHEMBL28678653 0.79 CYP3A4 (0.46) CYP3A4ALDH1A1TSHRTDP1POLB
SCHEMBL3871698 0.79 ALDH1A1 (0.52) CYP3A4ALDH1A1TSHRTDP1POLB
SCHEMBL767710 0.79 CYP3A4 (0.46) CYP3A4ALDH1A1TSHRTDP1POLB
SCHEMBL2906897 0.79 ALDH1A1 (0.52) CYP3A4ALDH1A1TSHRTDP1POLB
SCHEMBL6441444 0.77 CYP3A4 (0.41) CYP3A4ALDH1A1TSHRPOLBMAPT
Hydrochloric Acid SCHEMBL21879618 0.77 ALDH1A1 (0.50) CYP3A4ALDH1A1TSHRTDP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023009475-A1 ROCK2 INHIBITORS AND USES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-02-02 WO disclosed
US-20220395576-A1 MODULATORS OF BCL6 PROTEOLYSIS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. 2022-12-15 US disclosed
EP-2229140-B1 AZOMETHINE DIRECT DYES OR REDUCED PRECURSORS OF THESE DYES OBTAINED FROM 2-CHLORO-3-AMINO-6-METHYLPHENOL, AND HAIR DYEING METHOD STARTING FROM THESE DYES AND PRECURSORS OREAL (FR) 2011-08-03 EP disclosed
US-6960640-B2 Composition for optical material MITSUBISHI GAS CHEMICAL CO., LTD. (JP) 2005-11-01 US disclosed
US-20040147708-A1 Composition for optical material MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2004-07-29 US disclosed
EP-1426392-A1 COMPOSITION FOR OPTICAL MATERIAL MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2004-06-09 EP disclosed
US-5149367-A Build-up Prevention, Polymeric Additives BAYER AKTIENGESELLSCHAFT (DE) 1992-09-22 US disclosed
EP-0271781-B1 PRINTING INK MOBAY CORPORATION (US) 1992-05-27 EP disclosed
EP-0460482-A2 Printers colours BAYER AG (DE) 1991-12-11 EP disclosed
EP-0211326-B1 PRODUCTION OF GRAVURE INKS FOR ILLUSTRATIONS BAYER AG (DE) 1990-06-06 EP disclosed
EP-0271781-A2 Printing ink MOBAY CORPORATION (US) 1988-06-22 EP disclosed
US-4750935-A DYE CONTAINING POLYURETHANES MOBAY CORPORATION (US) 1988-06-14 US disclosed
US-4739042-A ESTERIFICATION OF AN HYDROXY PYRIDONE DYESTUFF WITH CARBOXYLIC PYRIDINE DYESTUFF BAYER AKTIENGESELLSCHAFT (DE) 1988-04-19 US disclosed
EP-0211326-A2 Production of gravure inks for illustrations BAYER AG (DE) 1987-02-25 EP disclosed
EP-0211325-A2 Method of making heliographic and flexographic printing inks BAYER AG (DE) 1987-02-25 EP disclosed
EP-0034945-B1 N-PHENYLPYRAZOLE DERIVATIVES MAY & BAKER LIMITED (GB) 1985-08-07 EP disclosed
US-4496390-A WEED-CONTRTOLLING HERBICIDES MAY & BAKER LIMITED (GB) 1985-01-29 US disclosed
EP-0034945-A2 N-phenylpyrazole derivatives MAY & BAKER LIMITED (GB) 1981-09-02 EP disclosed
US-4020068-A Chromogenic furoquinoxalines NCR CORPORATION (US) 1977-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220395576-A1 MODULATORS OF BCL6 PROTEOLYSIS AND ASSOCIATED METHODS OF USE BCL6, BCL6B, BCL3 CYP3A4 4540/4885ALDH1A1 3862/4885TSHR 3100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.